Enter your login e-mail to the account
Search
Search parameters
Search results
- NOVINKY VO FARMAKOTERAPII: KATEGORIZÁCIA OD 1. JÚLA 2008
Ing. Mgr. Dagmar Hroncová
(4-5/2008, Informations ) - Chronic myeloid leukemia – model of successful targeted therapy of oncologic disease
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD
(3-4/2014, Interdisciplinary consilium ) - Use of biological treatment in oncology
MUDr. Michal Mego, MUDr. Lucia Masárová
(6/2011, Review articles )
- Management of pacients with CML resistant or intolerant to tyrosine kinase inhibitor – imatinib
MUDr. Eva Mikušková, MUDr. Juraj Chudej, PhD., MUDr. Juraj Sokol, MUDr. Juraj Halička, MUDr. Ľubica Váleková, PhD., MUDr. Emília Flochová, PhD.
(4/2012, Topic of the year ) - Milí čitatelia! - úvodné slovo
prof. MUDr. Stanislav Špánik, CSc.
(1/2011, Editorial ) - Gastrointestinal stromal tumors
MUDr. Jozef Šufliarsky, PhD.
(1/2011, Review articles ) - Biological treatment and chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc.
(1/2011, Review articles ) - Anti-tumor therapy in patients with liver insufficiency
MUDr. Michal Mego, PhD., MUDr. Ján Rajec, PhD.
(1/2011, Review articles ) - Tyrosine kinase inhibitor sunitinib malate
MUDr. Patrick Palacka, PhD., MPH, MBA
(3/2013, Drugs & drug classes ) - Novinky z ASCO 2006
MUDr. Tomáš Šálek, MUDr. Radovan Barilla,
(3/2006, Events ) - Molecular markers of targeted therapy in oncology malignancies
RNDr. Katarína Hlinková
(2/2010, Review articles ) - Gastrointestinal stromal tumors and some new treatment options
MUDr. Iveta Andrezálová Vochyanová
(3/2015, Review articles ) - Gastrointestinal toxicity, hepatotoxicity and nephrotoxicity of targeted treatment
MUDr. Branislav Bystrický, MUDr. Alexandra Szabová
(1/2013, Main topic ) - Patient registries – a need for real data in the context of efficacy, safety and cost effectiveness
PharmDr. Dominik Tomek, MPH, RNDr. Mária Pšenková, Ing. Branislav Balvan
(2/2010, Review articles ) - Pneumotoxicity of molecularly targeted anticancer drugs
doc. MUDr. Peter Beržinec, CSc.
(1/2013, Main topic ) - Health technology assessment and value for money in drug policy
PharmDr. Martin Višňanský, MBA, PhD., MSc., Mgr. Radoslav Suchovič
(2/2017, Main topic ) - Cancer drug consumption 2012-2015
Ing. Tomáš Mesároš, MBA, JUDr. Ing. Štefan Mesároš, PhD.
(2/2017, Main topic ) - Gastrointestinal stromal tumors (GISTs)
MUDr. Iveta Andrezálová Vochyanová
(3/2011, Review articles ) - Cardiotoxicity of targeted cancer therapy
doc. MUDr. Beáta Mladosievičová, CSc., MUDr. Mária Rečková
(1/2013, Main topic ) - Future of treatment of chronic myeloid leukemia (CML)
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(5/2012, Main topic ) - Place of bosutinib in the therapy of chronic myeloid leukemia
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Angelika Bátorová, PhD.
(3/2016, Drugs & drug classes ) - Selected drug interactions in oncology
MUDr. Veronika Ballová, MUDr. Ján Rajec, PhD.
(5/2011, Review articles ) - GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, Review articles ) - ELN recommendations for management of CML patients 2013
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, PhD., MUDr. Antónia Hatalová, doc. MUDr. Angelika Bátorová, PhD.
(4/2014, Review articles ) - Správa z 15. kongresu Európskej hematologickej spoločnosti v Barcelone
MUDr. Ľudmila Demitrovičová
(5/2010, Events ) - Real life data on ponatinib treatment of chronic myeloid leukemia patients in Slovakia
MUDr. Katarína Slezáková, PhD., MUDr. Ľudmila Demitrovičová, PhD., MUDr. Iveta Oravcová, PhD., MUDr. Juraj Chudej, PhD., MUDr. Imrich Markuljak, MUDr. Alexander Wild, MUDr. Natália Štecová, prof. MUDr. Elena Tóthová, CSc., MUDr. Eva Mikušková, PhD., prof. MUDr. Angelika Bátorová, PhD.
(6/2020, Original articles ) - The incidence and management of side effects of tyrosinekinase inhibitors for treatment of chronic myeloid leukemia
prof. MUDr. Elena Tóthová, CSc., MUDr. Adriana Kafková, PhD.
(1/2015, Review articles ) - Nilotinib – inhibítor tyrozínkinázy na liečbu chronickej myelocytovej leukémie (CML)
doc. PharmDr. Juraj Sýkora, CSc.
(2/2009, Drugs & drug classes ) - Treatment alternatives in newly diagnosed patients with chronic myeloid leukemia
MUDr. Zuzana Sninská, PhD.
(3/2012, Topic of the year ) - Chronic myeloid leukemia and its treatment in patients with repeated intolerance of tyrosine kinase inhibitors
MUDr. Radoslav Greksák, PhD.
(2/2020, Case reports ) - CHRONIC MYELOID LEUKEMIA – NEW TRENDS IN THE TREATMENT
MUDr. Ľudmila Demitrovičová, MUDr. Eva Mikušková
(5/2008, Review articles ) - GASTROINTESTINAL STROMAL TUMOR – A COMPREHENSIVE VIEW OF DIAGNOSTICS AND TREATMENT
MUDr. Andrea Cipková, MPH.
(6/2008, Review articles ) - Therapy for chronic myeloid leukemia: Past, present and future
prof. MUDr. Elena Tóthová, CSc.
(1/2012, Topic of the year ) - TREATMENT OF CHRONIC MYELOID LEUKEMIA IN KHAT BRATISLAVA DURING 2002 – 2007
doc. MUDr. Martin Mistrík, PhD., MUDr. Zuzana Sninská, MUDr. Eva Demečková
(6/2008, Original articles ) - Treatment of gastrointestinal stromal tumours
MUDr. Zdeněk Linke, MUDr. Jana Prausová
(4/2010, Review articles ) - Management of chronic myeloid leukemia after failure of second generation tyrosine kinase inhibitors
MUDr. Katarína Slezáková, PhD., MUDr. Zuzana Sninská, PhD., doc. MUDr. Peter Rohoň, PhD., prof. MUDr. Angelika Bátorová, PhD.
(3/2022, Review articles )
- Mastocytosis – a comprehensive view of issues
MUDr. Klára Martinásková, PhD.
(1/2011, Review articles )
- GASTROINTESTINAL STROMAL TUMOR: A NEW ENTITY IN ONCOLOGY
MUDr. Jozef Šufliarsky
(2/2007, clearly )